查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1525968

乳癌復發評分測試市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033年

Breast Recurrence Score Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 233 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球乳癌復發評分測試市場的綜合報告。本報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。

關鍵見解

  • 乳癌復發評分測試市場規模（2024年）：2.59 億美元
  • 市場預測金額（2033年）：5.766 億美元
  • 全球市場成長率（2024年至2033年年複合成長率）：9.3%

乳癌復發評分測試市場：調查範圍

乳癌復發評分測試提供基於腫瘤組織基因圖譜的個人化風險評估，在指導乳癌患者的治療決策方面發揮重要作用。這些測試用於腫瘤診所、醫院和研究機構，以深入了解癌症復發的可能性和對輔助治療的反應。全球乳癌發病率的增加、提高檢測準確性的基因組技術的進步以及腫瘤學中個人化醫療方法的日益採用推動了市場成長。

推動市場成長的因素：

全球乳癌復發評分測試市場由幾個關鍵因素推動，包括所有年齡層和種族女性乳癌發生率的上升。下一代定序和多基因表現譜等技術進步有助於完善預後評估和治療計畫。此外，向強調成本效益和客製化治療策略的基於價值的醫療模式的轉變將進一步刺激市場擴張。此外，腫瘤學家、病理學家和分子診斷公司之間的合作推動測試開發和臨床驗證的創新。

市場限制因素：

儘管成長前景廣闊，但乳癌復發評分測試市場面臨著監管複雜性、地區償付差異以及基因組檢測廣泛臨床驗證需求等挑戰。檢測結果和解釋的可變性以及基因檢測技術的高成本是在資源有限的環境中廣泛使用的障礙。應對這些挑戰需要持續投資臨床研究、測試方案標準化以及倡導癌症護理中基因組測試的保險覆蓋範圍。

市場機會：

由於生物資訊學的進步、遺傳資料庫資源的擴大以及醫療保健專業人員對腫瘤學基因組測試臨床實用性的認識不斷提高，乳癌復發評分測試市場提供了巨大的成長機會。人工智慧和機器學習演算法的整合用於預測建模，再加上患者參與策略，可以提高診斷準確性和治療結果。此外，標靶治療伴隨診斷的出現和分散測試平台的開發日益增加可及性和患者便利性。

本報告解決的關鍵問題

  • 推動全球乳癌復發評分測試市場成長的關鍵因素是什麼？
  • 哪些類型的復發評分測試和基因分析技術在腫瘤學實踐中越來越受到重視？
  • 技術進步如何改變乳癌復發評分測試市場的競爭格局？
  • 誰是乳癌復發評分測驗市場的主要參與者？
  • 全球乳癌復發評分測試市場的新趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含/排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第4章 增值見解

  • 產品採用率分析
  • 產品 USP/特點
  • 各國的監理狀況
  • 近期產品核准/發布
  • 疾病流行病學
  • PESTLE分析
  • 價值鏈分析
  • 未滿足的需求

第5章 市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第6章 全球市場需求（單位）分析

  • 2019-2023年過去的市售（單位）分析
  • 2024-2033年當前及未來市場數量（單位）預測
    • 年成長趨勢分析

第7章 世界市場 - 價格分析

  • 區域價格分析：依產品分類
  • 世界平均價格分析基準
  • 定價假設

第8章 全球市場需求（金額或規模，百萬美元）分析

  • 2019-2023年過去的市值（百萬美元）分析
  • 2024-2033年當前及未來市場規模（百萬美元）預測
    • 年成長趨勢分析
    • 絕對數量機會分析
  • 利潤機會情境 - 趨勢/保守/樂觀

第9章 世界市場分析：依產品

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）和數量（單位）分析：依產品
  • 2024-2033年當前和未來市場規模（百萬美元）和數量（單位）的分析和預測：依產品
    • 測試套件
    • 試劑/消耗品
  • 市場吸引力分析：依產品分類

第10章 全球市場分析：依適應症

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）分析：依適應症
  • 2024-2033年當前和未來市場規模分析和預測（百萬美元）：依適應症
    • 1 期乳癌
    • 2 期乳癌
    • 雌激素受體陽性癌症
    • 淋巴結陰性癌症
  • 市場吸引力分析：依適應症

第11章 世界市場分析：依最終使用者

  • 簡介/主要發現
  • 2019-2023年歷史市場規模分析（百萬美元）：依最終使用者
  • 2024-2033年當前和未來市場規模（百萬美元）的分析和預測：依最終使用者
    • 醫院
    • 專科癌症中心
    • 診斷中心
    • 癌症研究所
  • 市場吸引力分析：依最終用戶

第12章 世界市場分析：依地區

  • 簡介/主要發現
  • 2019-2023年歷史市場規模（百萬美元）及數量（單位）分析：依地區
  • 2024-2033年當前和未來市場規模（百萬美元）和數量（單位）分析和預測：依地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東、非洲
  • 市場吸引力分析：依地區

第13章 北美市場分析

第14章 拉丁美洲市場分析

第15章 歐洲市場分析

第16章 東亞市場分析

第17章 南亞市場分析

第18章 大洋洲市場分析

第19章 中東、非洲市場分析

第20章 市場結構分析

  • 市場分析：依公司層級
  • 主要企業市佔率分析（%）
  • 市場現況分析

第21章 競爭分析

  • 競爭對手儀表板
  • 主要發展分析
  • 品牌與推廣策略：主要公司
  • 競爭詳情
    • Exact Sciences（Genome Health Inc.）
    • NanoString Technologies, Inc.
    • Foundation Medicine, Inc
    • ThermoFisher Scientific
    • Illumina, Inc
    • Hologic Inc（Biotheranostic）
    • Biocartis
    • Roche Diagnostics
    • Epic Sciences
    • Qiagen
    • Abbott
    • Myriad Genetics, Inc
    • Guardant Health

第22章 使用的先決條件與縮寫

第23章 研究方法

簡介目錄
Product Code: PMRREP32146

Persistence Market Research has recently released a comprehensive report on the global Breast Recurrence Score Test Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Breast Recurrence Score Test Market Size (2024E): USD 259 Million
  • Projected Market Value (2033F): USD 576.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.3%

Breast Recurrence Score Test Market - Report Scope:

The Breast Recurrence Score Test plays a crucial role in guiding treatment decisions for breast cancer patients, providing personalized risk assessment based on genetic profiling of tumor tissue. These tests are utilized in oncology clinics, hospitals, and research institutions, offering insights into the likelihood of cancer recurrence and response to adjuvant therapies. Market growth is driven by increasing incidence of breast cancer globally, advancements in genomic technologies enhancing test accuracy, and growing adoption of personalized medicine approaches in oncology.

Market Growth Drivers:

The global Breast Recurrence Score Test Market is propelled by several key factors, including the rising prevalence of breast cancer among women of all ages and ethnicities. Technological advancements, such as next-generation sequencing and multi-gene expression profiling, contribute to refining prognostic assessments and treatment planning. Moreover, the shift towards value-based healthcare models emphasizing cost-effective and tailored treatment strategies further stimulates market expansion. Additionally, collaborative efforts between oncologists, pathologists, and molecular diagnostic companies drive innovation in test development and clinical validation.

Market Restraints:

Despite promising growth prospects, the Breast Recurrence Score Test Market faces challenges related to regulatory complexities, reimbursement disparities across regions, and the need for extensive clinical validation of genomic assays. Variability in test results and interpretation, as well as the high cost of genetic testing technologies, pose barriers to widespread adoption in resource-limited settings. Addressing these challenges requires continuous investment in clinical research, standardization of testing protocols, and advocacy for insurance coverage of genomic testing in oncology practice.

Market Opportunities:

The Breast Recurrence Score Test Market presents significant growth opportunities driven by advancements in bioinformatics, expanded genetic database resources, and increasing awareness among healthcare professionals about the clinical utility of genomic testing in oncology. Integration of artificial intelligence and machine learning algorithms for predictive modeling, coupled with patient engagement strategies, enhances diagnostic accuracy and treatment outcomes. Furthermore, the emergence of companion diagnostics for targeted therapies and the development of decentralized testing platforms enhance accessibility and patient convenience.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Recurrence Score Test Market globally?
  • Which types of recurrence score tests and genetic profiling technologies are gaining prominence in oncology practice?
  • How are technological advancements reshaping the competitive landscape of the Breast Recurrence Score Test Market?
  • Who are the key players contributing to the Breast Recurrence Score Test Market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global Breast Recurrence Score Test Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Recurrence Score Test Market, including XYZ Genomics, ABC Diagnostics, and PQR Laboratories, focus on innovation, clinical validation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop novel biomarkers, enhance assay sensitivity, and expand testing capabilities across different breast cancer subtypes. Collaborations with oncologists, academic institutions, and patient advocacy groups facilitate market penetration and drive clinical adoption of genomic testing solutions. Moreover, emphasis on data transparency, patient privacy, and regulatory compliance underscores commitment to quality and ethical practice in the evolving oncology diagnostics landscape.

Key Companies Profiled:

  • Exact Sciences (Genome Health Inc.)
  • NanoString Technologies, Inc.
  • Foundation Medicine, Inc
  • ThermoFisher Scientific
  • Illumina, Inc
  • Hologic Inc (Biotheranostic)
  • Biocartis
  • Roche Diagnostics
  • Epic Sciences
  • Qiagen
  • Abbott
  • Myriad Genetics, Inc.
  • Guardant Health

Key Segments of Breast Recurrence Score Test Industry Research

Product:

  • Test Kits
  • Reagents & Consumables

Indication:

  • Stage 1 Breast Cancer
  • Stage 2 Breast Cancer
  • Estrogen-Receptor-Positive Cancer
  • Lymph-Node-Negative Cancer

End User:

  • Hospitals
  • Specialty Cancer Centers
  • Diagnostic Centers
  • Cancer Research Institutions

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4.Value Added Insights

  • 4.1. Product Adoption Analysis
  • 4.2. Product USPs/Features
  • 4.3. Regulatory Landscape, By Country
  • 4.4. Recent Product Approval/Launches
  • 4.5. Disease Epidemiology
  • 4.6. PESTLE Analysis
  • 4.7. Value Chain Analysis
  • 4.8. Unmet Needs

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Expenditure Outlook
    • 5.1.2. Global Life Science Market Outlook
    • 5.1.3. Global Breast Cancer Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Prevalence of Breast Cancer
    • 5.2.2. Increase in Research and Development
    • 5.2.3. Strategic Collaborations among players
    • 5.2.4. Cost of Product
    • 5.2.5. Adoption Rate
    • 5.2.6. Frequency of Product Approval
    • 5.2.7. Government Initiative
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Market Demand Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 6.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product
  • 7.2. Global Average Pricing Analysis Benchmark
  • 7.3. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 8.2. Current and Future Market Size (US$ Mn) Projections, 2024-2033
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis
  • 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 9.3.1. Test Kits
    • 9.3.2. Reagents & Consumables
  • 9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
    • 10.3.1. Stage 1 Breast Cancer
    • 10.3.2. Stage 2 Breast Cancer
    • 10.3.3. Estrogen-receptor Positive Cancer
    • 10.3.4. Lymph-node Negative Cancer
  • 10.4. Market Attractiveness Analysis By Indication

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Cancer Centers
    • 11.3.3. Diagnostic Centers
    • 11.3.4. Cancer Research Institutions
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis By Region
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Market trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Indication
        • 13.8.1.2.3. By End User
    • 13.8.2. Canada Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Indication
        • 13.8.2.2.3. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction / Key Findings
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis By Region
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Brazil Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By End User
    • 14.8.2. Mexico Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Indication
        • 14.8.3.2.3. Type By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction / Key Findings
  • 15.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Spain
      • 15.3.1.4. Russia
      • 15.3.1.5. Italy
      • 15.3.1.6. BENELUX
      • 15.3.1.7. U.K.
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis By Region
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By End User
  • 15.5. Market trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By End User
    • 15.8.2. France Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By End User
    • 15.8.3. Spain Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. Type By End User
    • 15.8.4. Russia Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Indication
        • 15.8.4.2.3. Type By End User
    • 15.8.5. Italy Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Indication
        • 15.8.5.2.3. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Indication
        • 15.8.6.2.3. By End User
    • 15.8.7. U.K. Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Indication
        • 15.8.7.2.3. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction / Key Findings
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis By Region
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction / Key Findings
  • 17.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Thailand
      • 17.3.1.4. Philippines
      • 17.3.1.5. Malaysia
      • 17.3.1.6. Vietnam
      • 17.3.1.7. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis By Region
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Market trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By End User
    • 17.8.3. Thailand Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By End User
    • 17.8.4. Philippines Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Indication
        • 17.8.4.2.3. By End User
    • 17.8.5. Malaysia Market Analysis
      • 17.8.5.1. Introduction
      • 17.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.5.2.1. By Product
        • 17.8.5.2.2. By Indication
        • 17.8.5.2.3. By End User
    • 17.8.6. Vietnam Market Analysis
      • 17.8.6.1. Introduction
      • 17.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.6.2.1. By Product
        • 17.8.6.2.2. By Indication
        • 17.8.6.2.3. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction / Key Findings
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis By Region
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By End User
  • 18.5. Market trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By End User

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction / Key Findings
  • 19.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Egypt
      • 19.3.1.4. Israel
      • 19.3.1.5. South Africa
      • 19.3.1.6. Northern Africa
      • 19.3.1.7. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis By Region
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By End User
  • 19.5. Market trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By End User
    • 19.8.3. Egypt Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Indication
        • 19.8.3.2.3. By End User
    • 19.8.4. Israel Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Indication
        • 19.8.4.2.3. By End User
    • 19.8.5. South Africa Market Analysis
      • 19.8.5.1. Introduction
      • 19.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.5.2.1. By Product
        • 19.8.5.2.2. By Indication
        • 19.8.5.2.3. By End User
    • 19.8.6. Northern Africa Market Analysis
      • 19.8.6.1. Introduction
      • 19.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.6.2.1. By Product
        • 19.8.6.2.2. By Indication
        • 19.8.6.2.3. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. Regional Footprint of Players
    • 20.3.2. Product Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Key Development Analysis
  • 21.3. Branding and Promotional Strategies, By Key Players
  • 21.4. Competition Deep Dive
    • 21.4.1. Exact Sciences (Genome Health Inc.)
      • 21.4.1.1. Overview
      • 21.4.1.2. Product Portfolio
      • 21.4.1.3. Key Financials
      • 21.4.1.4. Sales Footprint
      • 21.4.1.5. SWOT Analysis
      • 21.4.1.6. Strategy Overview
        • 21.4.1.6.1. Marketing Strategies
        • 21.4.1.6.2. Channel Strategies
        • 21.4.1.6.3. Product Strategies
    • 21.4.2. NanoString Technologies, Inc.
      • 21.4.2.1. Overview
      • 21.4.2.2. Product Portfolio
      • 21.4.2.3. Key Financials
      • 21.4.2.4. Sales Footprint
      • 21.4.2.5. SWOT Analysis
      • 21.4.2.6. Strategy Overview
        • 21.4.2.6.1. Marketing Strategies
        • 21.4.2.6.2. Channel Strategies
        • 21.4.2.6.3. Product Strategies
    • 21.4.3. Foundation Medicine, Inc
      • 21.4.3.1. Overview
      • 21.4.3.2. Product Portfolio
      • 21.4.3.3. Key Financials
      • 21.4.3.4. Sales Footprint
      • 21.4.3.5. SWOT Analysis
      • 21.4.3.6. Strategy Overview
        • 21.4.3.6.1. Marketing Strategies
        • 21.4.3.6.2. Channel Strategies
        • 21.4.3.6.3. Product Strategies
    • 21.4.4. ThermoFisher Scientific
      • 21.4.4.1. Overview
      • 21.4.4.2. Product Portfolio
      • 21.4.4.3. Key Financials
      • 21.4.4.4. Sales Footprint
      • 21.4.4.5. SWOT Analysis
      • 21.4.4.6. Strategy Overview
        • 21.4.4.6.1. Marketing Strategies
        • 21.4.4.6.2. Channel Strategies
        • 21.4.4.6.3. Product Strategies
    • 21.4.5. Illumina, Inc
      • 21.4.5.1. Overview
      • 21.4.5.2. Product Portfolio
      • 21.4.5.3. Key Financials
      • 21.4.5.4. Sales Footprint
      • 21.4.5.5. SWOT Analysis
      • 21.4.5.6. Strategy Overview
        • 21.4.5.6.1. Marketing Strategies
        • 21.4.5.6.2. Channel Strategies
        • 21.4.5.6.3. Product Strategies
    • 21.4.6. Hologic Inc (Biotheranostic)
      • 21.4.6.1. Overview
      • 21.4.6.2. Product Portfolio
      • 21.4.6.3. Key Financials
      • 21.4.6.4. Sales Footprint
      • 21.4.6.5. SWOT Analysis
      • 21.4.6.6. Strategy Overview
        • 21.4.6.6.1. Marketing Strategies
        • 21.4.6.6.2. Channel Strategies
        • 21.4.6.6.3. Product Strategies
    • 21.4.7. Biocartis
      • 21.4.7.1. Overview
      • 21.4.7.2. Product Portfolio
      • 21.4.7.3. Key Financials
      • 21.4.7.4. Sales Footprint
      • 21.4.7.5. SWOT Analysis
      • 21.4.7.6. Strategy Overview
        • 21.4.7.6.1. Marketing Strategies
        • 21.4.7.6.2. Channel Strategies
        • 21.4.7.6.3. Product Strategies
    • 21.4.8. Roche Diagnostics
      • 21.4.8.1. Overview
      • 21.4.8.2. Product Portfolio
      • 21.4.8.3. Key Financials
      • 21.4.8.4. Sales Footprint
      • 21.4.8.5. SWOT Analysis
      • 21.4.8.6. Strategy Overview
        • 21.4.8.6.1. Marketing Strategies
        • 21.4.8.6.2. Channel Strategies
        • 21.4.8.6.3. Product Strategies
    • 21.4.9. Epic Sciences
      • 21.4.9.1. Overview
      • 21.4.9.2. Product Portfolio
      • 21.4.9.3. Key Financials
      • 21.4.9.4. Sales Footprint
      • 21.4.9.5. SWOT Analysis
      • 21.4.9.6. Strategy Overview
        • 21.4.9.6.1. Marketing Strategies
        • 21.4.9.6.2. Channel Strategies
        • 21.4.9.6.3. Product Strategies
    • 21.4.10. Qiagen
      • 21.4.10.1. Overview
      • 21.4.10.2. Product Portfolio
      • 21.4.10.3. Key Financials
      • 21.4.10.4. Sales Footprint
      • 21.4.10.5. SWOT Analysis
      • 21.4.10.6. Strategy Overview
        • 21.4.10.6.1. Marketing Strategies
        • 21.4.10.6.2. Channel Strategies
        • 21.4.10.6.3. Product Strategies
    • 21.4.11. Abbott
      • 21.4.11.1. Overview
      • 21.4.11.2. Product Portfolio
      • 21.4.11.3. Key Financials
      • 21.4.11.4. Sales Footprint
      • 21.4.11.5. SWOT Analysis
      • 21.4.11.6. Strategy Overview
        • 21.4.11.6.1. Marketing Strategies
        • 21.4.11.6.2. Channel Strategies
        • 21.4.11.6.3. Product Strategies
    • 21.4.12. Myriad Genetics, Inc
      • 21.4.12.1. Overview
      • 21.4.12.2. Product Portfolio
      • 21.4.12.3. Key Financials
      • 21.4.12.4. Sales Footprint
      • 21.4.12.5. SWOT Analysis
      • 21.4.12.6. Strategy Overview
        • 21.4.12.6.1. Marketing Strategies
        • 21.4.12.6.2. Channel Strategies
        • 21.4.12.6.3. Product Strategies
    • 21.4.13. Guardant Health
      • 21.4.13.1. Overview
      • 21.4.13.2. Product Portfolio
      • 21.4.13.3. Key Financials
      • 21.4.13.4. Sales Footprint
      • 21.4.13.5. SWOT Analysis
      • 21.4.13.6. Strategy Overview
        • 21.4.13.6.1. Marketing Strategies
        • 21.4.13.6.2. Channel Strategies
        • 21.4.13.6.3. Product Strategies

22. Assumptions and Acronyms Used

23. Research Methodology